Business / Finance

RSS

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.

2 Sep 2014

BIOREM announces three new orders totalling $2.1 million

BIOREM Inc. today announced three new orders totalling $2.1 million. The orders consist of three large odour control systems for waste water treatment plants in Canada.

2 Sep 2014

USPTO issues three standard essential patents to Spherix

Spherix Incorporated -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.

2 Sep 2014

Pfenex reports total revenue of $3.3 million for second quarter 2014

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today provided a business update and reported financial results for the second quarter ended June 30, 2014.

30 Aug 2014

BC Technical closes acquisition of Polaris Medical Imaging

BC Technical, the nation's leading non-OEM provider of Medical Imaging Solutions, has acquired Polaris Medical Imaging, a leader in sales, service and installation of GE MRI and CT scanners.

30 Aug 2014

iCo Therapeutics reports financial results for second quarter 2014

iCo Therapeutics, today reported financial results for the six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").

29 Aug 2014

Pixcelldata, eX-Path announce major new deal in advance of ECP 2014

Pixcelldata, the innovative Irish developer of digital pathology management and collaboration software has announced a major new deal with Dutch based eX-Path, global providers of tele-pathology services, founded by renowned pathology expert, Dr. Marius Nap.

29 Aug 2014

CCA Industries sells Mega-T brand to a group formed by Casla Partners

CCA Industries, Inc. announced today that it has sold its weight loss business, marketed under the Mega-T brand, to a group formed by Casla Partners Capital Fund I, LP.

28 Aug 2014

HICCC receives $18 million grant from the National Cancer Institute

Outstanding basic research, a growing focus on translating discoveries into treatments, and a dedication to patient care have earned the Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 million, five-year Cancer Center Support Grant from the National Cancer Institute (NCI).

28 Aug 2014

MedEquities Realty Trust closes initial private placement of $163.9 million common stock

MedEquities Realty Trust, Inc., a newly formed, self-managed and self-administered company that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments, announced today that during July and August 2014 it completed an initial private placement of $163.9 million of its common stock.

28 Aug 2014

Armetheon raises $7 million in first round of financing

Armetheon, Inc., a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing.

28 Aug 2014

Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

The Co-development Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies.

28 Aug 2014

Nepstar's Q2 2014 revenue increases by 7.5% to RMB686.6 million (US$110.7 million)

China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2014.

28 Aug 2014

Americana announces strategic partnership with COMS Interactive

Americana Corporation is pleased to announce a strategic partnership with COMS Interactive, LLC (Clinical Outcomes Management Systems or COMS). The partnership supports an interface between Americana Corporation's AmeraCare products/services and the COMS Daylight IQ™ disease management software.

26 Aug 2014

Leading European IT company invests $3 million in LogicNets

LogicNets, Inc., the web-based Expert Decision Support platform used for automating complex decision-making processes, announces an investment of $3 million from ICT Automatisering (Euronext: ICT:NA), a leading European IT services company headquartered in the Netherlands.

25 Aug 2014

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform.

25 Aug 2014

Aldea Pharmaceuticals announces closure of $24M Series B equity financing

Aldea Pharmaceuticals, a company pioneering novel therapeutics to treat aldehyde metabolism disorders, today announced that it has closed a $24 million Series B equity financing.

25 Aug 2014

ESAOTE launches MyLab™Six at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology, Barcelona, 30th August - 3rd September). Configured for an extensive range of applications, MyLab™Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting.

24 Aug 2014

ESAOTE launches MyLab™Gamma at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable “green” ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote’s productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment’s notice.

24 Aug 2014